The global transradial access devices market size was valued at USD 2.96 billion in 2025 and is projected to grow from USD 3.21 billion in 2026 to USD 6.07 billion by 2034, registering a CAGR of 8.3% during the forecast period from 2026 to 2034. North America dominated the transradial access devices market with a market share of 38.5% in 2025.
Transradial access devices are medical devices used to gain access to the arterial system through the radial artery in the wrist during diagnostic and interventional cardiovascular procedures. They help improve procedural safety, reduce bleeding complications, and support faster patient recovery compared with traditional femoral artery access.
Download a Free Sample To learn more about this report,
Growing Adoption of Radial-First Approaches in Cardiovascular Interventions
The market is shifting toward radial artery access as clinicians increasingly use the wrist-based approach for coronary and peripheral vascular procedures. Compared with femoral access, transradial procedures can reduce bleeding and vascular complications while supporting earlier patient ambulation and discharge. This broader clinical adoption increases demand for radial access kits, introducer sheaths, guidewires, and related access products.
Increasing Focus on Patent Hemostasis and Radial Artery Preservation
Transradial access technology is increasingly emphasizing controlled post-procedure compression that achieves hemostasis while maintaining radial artery patency. This is encouraging development and adoption of dedicated compression devices with adjustable pressure and monitoring features, as radial artery occlusion remains an important access-related complication.
Expansion of Transradial Coronary and Peripheral Procedures Increases Device Demand
The growing use of transradial access across coronary and peripheral interventions is increasing requirements for specialized access devices. Clinicians use radial access because it can reduce bleeding and vascular complications and enable faster post-procedure recovery compared with femoral access. As radial-first strategies expand into additional vascular procedures, demand for dedicated access kits and supporting devices increases.
Operator Training and Technical Requirements Limit Consistent Transradial Adoption
Transradial procedures require appropriate patient selection, access-site assessment, specialized technique, and operator proficiency. Radial artery spasm, anatomical variation, and radial artery occlusion can complicate procedures and require clinicians to maintain specific skills. These technical requirements can slow adoption in facilities where experience with radial access remains limited.
Expansion of Radial Access Into Peripheral Interventions Creates New Device Applications
The increasing use of radial access for peripheral and noncoronary interventions creates opportunities for longer access devices, specialized sheaths, guidewires, and procedure-specific kits. As clinicians use the radial route for interventions involving vessels beyond the coronary circulation, manufacturers can develop devices suited to greater procedural reach and different anatomical requirements.
Preventing Radial Artery Occlusion While Achieving Effective Hemostasis Remains Difficult
Device manufacturers must balance sufficient compression to control bleeding with preservation of radial artery blood flow after catheter removal. Excessive or prolonged compression can contribute to radial artery occlusion, while inadequate compression can increase bleeding risk. This creates a technical challenge for manufacturers developing compression bands and post-procedure hemostasis systems.
The catheters segment accounted for the largest share of the global transradial access devices market, holding 31.4% in 2025. The segment dominates due to the widespread use of catheters in coronary angiography and percutaneous coronary intervention (PCI) procedures. Increasing demand for minimally invasive cardiovascular interventions, along with advancements in catheter design that improve flexibility, navigation, and procedural efficiency, continues to support the segment's leading position.
Request Customizationto receive a tailored report.
The diagnostics & testing segment is expected to witness the fastest growth, registering a CAGR of 8.5% during the forecast period (2026–2034). The growth is driven by the rising number of diagnostic angiography procedures, increasing prevalence of cardiovascular diseases, and growing preference for transradial access due to its lower complication rates and faster patient recovery. Continuous improvements in diagnostic imaging technologies are further supporting segment growth.
The hospitals segment accounted for the largest share of the global transradial access devices market, holding 58.6% in 2025. The segment's dominance is attributed to the high volume of cardiovascular procedures performed in hospitals, the availability of advanced catheterization laboratories, and the presence of skilled interventional cardiologists. Increasing investments in healthcare infrastructure and the growing adoption of minimally invasive cardiac procedures continue to strengthen the demand for transradial access devices in hospital settings.
Speak to an Analystto discuss market opportunities.
North America dominated the global transradial access devices market, accounting for 38.5% of the market in 2025, valued at USD 1.14 billion, and is projected to grow at a CAGR of 7.4% during the forecast period. The region's leadership is driven by the high prevalence of cardiovascular diseases, widespread adoption of minimally invasive procedures, advanced catheterization laboratories, and favourable reimbursement policies. Continuous technological innovations and the strong presence of leading medical device manufacturers further support regional market growth.
The U.S. transradial access devices market was valued at USD 0.92 billion in 2025. The country dominates the regional market due to the increasing volume of coronary angiography and percutaneous coronary intervention (PCI) procedures, advanced healthcare infrastructure, and growing preference for transradial access to reduce complications and improve patient outcomes.
The Canada transradial access devices market was valued at USD 0.22 billion in 2025. Growth is supported by increasing adoption of minimally invasive cardiovascular procedures, expanding access to advanced cardiac care, and rising investments in modern healthcare infrastructure. Growing awareness of the clinical benefits of transradial interventions is further driving market demand.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for 28.2% of the global transradial access devices market in 2025, reaching USD 0.83 billion, and is expected to grow at a CAGR of 8.6% during the forecast period. The region's growth is driven by increasing cardiovascular disease prevalence, favourable clinical guidelines supporting radial access, expanding adoption of minimally invasive interventions, and strong investments in healthcare innovation.
The UK transradial access devices market was valued at USD 0.25 billion in 2025. Rising demand for minimally invasive cardiovascular procedures, well-established cardiac care centres, and increasing adoption of advanced vascular access technologies continue to support market growth.
The Germany transradial access devices market was valued at USD 0.35 billion in 2025. Growth is driven by advanced healthcare infrastructure, increasing use of transradial interventions, and the presence of leading cardiovascular treatment centres. Continuous investment in innovative medical technologies further strengthens the market.
Asia Pacific held 22.7% of the global transradial access devices market in 2025, valued at USD 0.67 billion, and is projected to grow at a CAGR of 8.3% during the forecast period. The region is experiencing strong growth due to improving healthcare infrastructure, increasing cardiovascular disease burden, rising healthcare expenditure, and expanding access to minimally invasive cardiac procedures across developing economies.
The Japan transradial access devices market was valued at USD 0.21 billion in 2025. The country's advanced healthcare system, high adoption of minimally invasive cardiovascular procedures, and growing elderly population continue to drive demand for transradial access devices.
The China transradial access devices market was valued at USD 0.31 billion in 2025. Rapid expansion of healthcare infrastructure, increasing investments in cardiovascular care, rising incidence of heart disease, and growing adoption of advanced interventional cardiology procedures are supporting market growth.
The Middle East & Africa accounted for 4.5% of the global transradial access devices market in 2025, with a market value of USD 0.13 billion, and is projected to grow at a CAGR of 6.8% during the forecast period. Increasing investments in healthcare infrastructure, improving access to cardiovascular care, and growing awareness of minimally invasive procedures are contributing to market expansion across the region.
The UAE transradial access devices market was valued at USD 0.05 billion in 2025. Market growth is supported by increasing investments in advanced cardiac care facilities, rapid adoption of innovative medical technologies, and government initiatives to strengthen healthcare infrastructure.
The Africa transradial access devices market was valued at USD 0.08 billion in 2025. Growth is driven by improving access to cardiovascular healthcare, rising investments in hospital infrastructure, increasing awareness of minimally invasive interventions, and expanding healthcare services across several African countries.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Aerosol Delivery Devices Market Size, Share, Growth, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
Active Wheelchair Market Size, Share, Growth, Forecast, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
Advanced Wound Care Market Size, Share, Growth, Analysis, 2034
Acute Wound Care Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com